Detalhe da pesquisa
1.
Secukinumab in the treatment for patients with juvenile enthesitis related arthritis non-responsive to anti-TNF treatment according the Juvenile Spondyloarthritis Disease Activity Index.
Clin Exp Rheumatol
; 40(3): 620-624, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128790